Most people treat high cholesterol with statins and diet changes. But if insulin resistance is driving your lipid profile, neither will work as well as expected. Here’s the connection, and what to do about it.
Why diet alone doesn’t explain most cases of high cholesterol
You’ve been told your cholesterol is high and that you need to cut back on saturated fat and go on a “cholesterol-lowering diet”. So you’ve swapped butter for olive oil, cut back on red meat and eggs, and added more vegetables. Yet your cholesterol numbers barely budge. Sound familiar?
One of the most overlooked factors is insulin. Insulin’s role extends far beyond its most well-known function of regulating blood sugar, with high insulin levels directly affecting lipid metabolism in the body.
For most people, dietary cholesterol has a surprisingly modest effect on blood cholesterol than we’ve been led to believe; that is because your liver manufactures roughly 80% of it.
What can really shift production into overdrive is chronically elevated insulin, the hormone released whenever blood sugar rises. If your cells have become resistant to insulin’s signal, your body compensates by producing more of it. Over time, that excess insulin reshapes your entire lipid profile in ways that only cutting out saturated fats cannot reverse.
A key part of what I support clients with is improving insulin sensitivity, which, in turn, positively affects cholesterol and other cardiometabolic markers. This is a core part of 1-1 personalised nutrition support.
The Mechanism – how insulin resistance drives your lipid profile
Here’s the cascade that can happen inside your body if insulin resistance is at play:
- Hyperinsulinaemia – Persistently high insulin tells your liver to ramp up production of Very Low Density Lipoprotein (VLDL) particles, which carry triglycerides into your bloodstream.
- Triglycerides rise – The liver converts excess glucose in the blood to triglycerides. More VLDL means more triglycerides circulating after meals and even while fasting.
- High-Density Lipoprotein (HDL) falls – High triglycerides accelerate the clearance of HDL (“good”) cholesterol by the liver, so levels drop.
- Low-Density Lipoprotein (LDL) size shifts toward small, dense particles – These are more likely to penetrate artery walls and oxidise, driving atherogenic plaque formation. This can happen even when your total LDL-C number looks “acceptable”.
This pattern (high triglycerides, low HDL, small dense LDL) is the hallmark of metabolic dyslipidaemia, and it tracks closely with insulin resistance and increased cardiovascular risk – something we test for in clinic frequently with clients.
The triglyceride-to-HDL ratio – your best proxy for insulin resistance on a standard panel
A good indicator that insulin resistance may be part of your picture is your fasting triglyceride-to-HDL ratio, which you can find on a standard lipid panel. Take your fasting triglyceride level and divide it by your HDL (both in the same units).
- Below 1.2 (mmol/L) or 100 (mg/dL): Considered optimal.
- Above 1.7 (mmol/L) or 150 (mg/dL): Suggests significant insulin resistance and a predominance of small, dense LDL.
This simple ratio often predicts cardiovascular events and metabolic problems that LDL-C alone may miss, but it is only one metric that forms part of a much more complex picture.
Cardiometabolic panels are valuable because they assess interconnected physiological systems, helping you to understand your health beyond standard markers alone.
By testing cholesterol biomarkers that are not routinely screened by a GP, these panels reveal how your body is managing blood sugar regulation, cholesterol transport, inflammation, vascular stress, liver function, kidney function, and overall metabolic health – the same systems that drive increased risk for conditions such as Type 2 Diabetes, Atherosclerosis, Stroke, Metabolic Syndrome, and Fatty Liver Disease (MASLD).
Cardiometabolic disease processes typically develop silently over many years before symptoms appear – if they appear at all. Very often, cardiometabolic issues are completely asymptomatic. I also see a lot of clients who have normalised symptoms – low energy, cravings, stubborn weight gain, poor sleep, waking still tired, headaches – all ways the body tries to warn you.
Comprehensive testing can identify patterns of early dysfunction long before overt disease develops and often at a stage where intervention through lifestyle, nutrition, exercise, sleep optimisation, and targeted supplementation is still highly effective and potentially preventable.
If you want to read more about the additional cardiometabolic testing we recommend at Integral Wellness, you can find all the information and more by downloading our guide, Cholesterol Explained.
Why statins don’t truly address insulin-driven cholesterol
Statins are excellent at lowering LDL-C by blocking cholesterol synthesis in the liver. But statins don’t address VLDL overproduction, nor do they correct the underlying insulin problem.
In fact, research shows that statin therapy is associated with a slightly increased risk of developing type 2 diabetes, particularly in individuals who already have underlying insulin resistance or metabolic risk factors.
If insulin resistance is the driver, the LDL numbers may come down, but triglycerides can remain elevated, HDL may remain low, and your overall particle profile could stay unfavourable. This can be why some people still go on to have cardiovascular events despite taking statins and why addressing the metabolic drivers really matters.
If this sounds familiar, a comprehensive cardiometabolic panel could be highly relevant in helping to understand the factors behind your symptoms and persistent biomarkers. You can learn more about the test by booking a free call.
The tests that reveal whether insulin resistance is behind your cholesterol
Standard blood panels rarely include insulin markers, which means early opportunities for intervention are missed, as these markers can help identify metabolic issues years before they show up on standard panels. These tests expose the metabolic driver that a cholesterol panel alone will miss.
GPs will run these panels to confirm diagnosis, such as Type 1 Diabetes, but for preventative use, to avoid Type 2 Diabetes and other cardiometabolic conditions, they would need to be done privately:
- Fasting insulin – The conventional range is below 25 mIU/L; although there is no general consensus on what is optimal, research shows that levels consistently above 10 mIU/L are suggestive of insulin resistance and metabolic derangement, so aiming for a level below 10 mIU/L should be encouraged.
- HOMA-IR – A blood test that measures fasting insulin and glucose to assess insulin sensitivity. A score below 1 is considered a healthy insulin range. A score above 2.0 is associated with insulin resistance and metabolic dysregulation.
How does improving blood sugar change your lipid profile? Here’s what the evidence shows
The positive news is that if you reduce insulin resistance, then the lipid cascade has an opportunity to reverse:
- Research shows that triglycerides fall by 20% within 6 months of following a low- carbohydrate diet, with one study showing a 42% reduction within 2 weeks.
- HDL rises more slowly with meaningful improvements over 3-6 months.
- Studies show that LDL particle size shifts toward larger, more buoyant (less harmful) forms as insulin levels normalise.
Exercise accelerates every part of this process, from lowering VLDL and triglyceride levels to increasing HDL and improving insulin sensitivity, independent of weight loss.
Combining dietary change with regular physical activity provides the most consistent results. Change is achievable and within your reach.
The dietary changes with the strongest evidence for insulin-driven cholesterol
The latest guidance maintains focus on nutrient-dense whole foods and adequate protein, fibre and healthy fats
- Prioritise: Non-starchy vegetables, beans, lentils and legumes, nuts and seeds, oily fish (omega-3), fibre-rich whole grains and olive oil.
- Reduce: Ultra-processed foods, refined carbohydrates, added sugars, and alcohol, all of which spike insulin and directly raise hepatic triglyceride synthesis.
- Reconsider: Fat is not the enemy it was once made out to be. Healthy fats should be encouraged, and for many people with insulin-driven dyslipidaemia, reducing sugar and refined starch has a far greater impact than avoiding foods like eggs or red meat. Saturated fat may still matter for some individuals, but it is often not the main driver in this scenario.
If you struggle to digest fats, then it may be a sign that your gallbladder and bile flow may need support, which can lead to increased cholesterol. If this sounds like you, then you can read more about how these link to metabolic disease here.
- How you eat: Studies show that meal timing and frequency are also important for improving insulin sensitivity and metabolic health.
This approach is not about deprivation. It is about giving the body an abundance of the nutrients it needs to improve insulin sensitivity and learning about the foods and eating patterns that disrupt metabolic health.
How taking an integrated and personalised approach looks beyond the standard numbers.
Here at Integral Wellness, we look beyond a single cholesterol reading to understand the broader metabolic picture. Using advanced functional testing, personalised nutrition strategies, and ongoing guidance, we help uncover the insulin resistance driving your lipid profile, with a focus on improving long-term metabolic health. That’s exactly why we designed our Personalised 1-1 Cholesterol Nutrition support.
